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1. SUMMARY 
Urinary tract infections (UTI), such as cystitis or pyelonephritis, affect a large proportion 
of the world population and most of these infections are caused by UPEC bearing distinct 
virulence factors. Immune mediators established to be of importance for innate immune 
defense against UPEC include antimicrobial substances such as reactive oxygen species, 
exfoliation of uroepithelial cells and infiltration of neutrophil granulocytes (NΦG). In many 
infections, also macrophages (MΦ) and dendritic cells (DC) have been shown to be recruited 
by various chemokine receptors to sites of infection. Recruitment and functional role of these 
cells in UTI, however, are unknown. The present study aimed at answering these open 
questions. 
To this end, a murine infection model facilitated by instillation of UPEC into the bladder 
was established. Vesical infection caused recruitment of large numbers of NΦG, DC and MФ 
to the bladder submucosa and to the uroepithelium. Most DC exhibited the CD11b+ F4/80+ 
CD8α– Gr1–subtype. In addition, also CCR2-dependent CD11bINT DC producing iNOS and 
TNFα (Tip-DC) were detected, which have previously been shown to be crucial for the 
defense against other bacterial infections. However, CCR2-deficient mice that lacked the 
Tip-DC subset showed unimpaired clearance of UPEC from the infected bladder. Also mice 
devoid of DC, including the Tip-DC subset, remained capable of effective innate clearance of 
UPEC. However, DC were found to be efficient at phagocytosis of UPEC. This uptake 
strongly correlated with expression of MHC class II and costimulatory molecules, which were 
dependent on CCR2. These findings demonstrate that DC are dispensable for innate immunity 
against UPEC, but suggest a role in induction of adaptive immunity. 
In addition to DC, two subsets of MΦ, CX3CR1-expressing Gr1LO MФ and 
CCR2-expressing Gr1HI MФ, were found in infected bladders. These subsets have been 
described in other infections, but it remained unresolved whether they exerted distinct 
immune effector functions. In UTI, only Gr1LO MФ produced iNOS, whereas Gr1HI MФ 
effectively produced TNFα. All phagocytes examined produced ß1 defensins and not only 
epithelial cells as previously proposed. Interestingly, NΦG were most active at phagocytosis 
of UPEC. These findings are the first to reveal functional differences between Gr1LO and 
Gr1HI MФ in infection.  
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Moreover, the factors responsible for egress and immigration of MФ in UTI were 
identified using a recently described in vivo labeling technique. Finally, CCR2 contributed to 
the abundance of monocytes in the blood and the bladder and may affected the release of 
monocytes from the bone marrow (BM) into the circulation.  
In conclusion, the present study revealed mechanisms important in recruitment, migration 
and for expression of effector functions by different phagocyte cell types against bacterial 
infections. These findings advance our understanding of immunity against bacterial infections 
and extended the molecular mechanism important for egress and immigration of monocytes 
throughout the organism.  
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3. ABBREVIATIONS 
APC Antigen Presenting Cell 
BM Bone marrow 
CCL Chemokine Ligand 
CCR Chemokine Receptor 
CDC Conventional DC 
CFU Colony Forming Unit 
Clo-lip Clodronate-Liposomes 
CPS E.coli Proteus Streptococcus  
DC Dendritic Cell 
DT  Diphteria Toxin 
E.coli Escherichia coli 
EDTA Ethylenediaminetetra-acetic acid  
EGF Epidermal Growth Factor 
EM Electron Microscopy 
FCS Foetal Calf Serum 
GFP Green Fluorescent Protein 
Het Heterozygeous 
ICAM-1 Intracellular Adhesion Molecule 
IF Immunofluorescence 
IFN Interferon 
IHC Immunohistochemistry 
IL Interleukin 
iNOS inducible Nitric Oxide Synthetase 
LC Langerhans cell 
LN Lymph Node 
Lx Latex 
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M Molar 
MCP-1 Macrophage Chemoattractant Protein-1 
M-CSF Macrophage- Colony Stimulating Factor 
MFI Mean Fluorescence Intensity 
MHC Major Histocompatibility Complex 
MIP-2 Macrophage Inflammatory Protein-2 
mL milli Liter 
mM milli Molar 
MФ  Macrophage 
ng nano Gramm 
NO Nitric oxide 
NΦG Neutrophil Granulocyte 
pDC plasmacytoid DC 
PMN Polymorphnuclear cells 
RANTES Regulated on Activation, Normal T-cell Expressed and Secreted 
RCB Red blood cell removal buffer 
TGF-ß Transforming Growth Factor - beta 
Tip-DC TNFα iNOS producing – Dendritic Cell 
TLR Toll Like Receptor 
TNF Tumor Necrosis Factor 
UPEC Uropathogenic E.coli 
UTI Urinary Tract Infection 
VCAM-1 Vascular Cell Adhesion Molecule-1 
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4. INTRODUCTION 
4.1. UPEC in UTI 
UTI, such as cystitis or pyelonephritis, are among the most prevalent infections and 
account for significant morbidity and medical costs in developed countries (36). Most of these 
infections are caused by UPEC bearing distinct virulence factors, such as fimbriae or pili. 
These factors can be monomers, simple oligomers or supramolecular fibers (43) and facilitate 
bacterial attachment to uroepithelial cells, bacterial ascension from the bladder to the kidney 
and organ infiltration (54). 
4.2. Defense mechanisms of the infected host 
Various defense mechanisms protect the body from UTI. Uroepithelial cells secrete 
antimicrobial agents (79), or are exfoliated when infected by UPEC (54). Among the immune 
cells involved in the defense against UTI, NΦG play a crucial role (27). These non-resident 
cells are attracted by mediators such as CXCL8 (MIP-2) (32) or TNFα (48). Sensing of 
bacteria by immune cells can occur by toll-like receptors (TLR) (83). In particular, TLR4 
recognizes LPS in gram-negative bacteria (65), while TLR11 responded to unidentified 
molecular patterns unique to UPEC (94). Recently, it has been shown that TLR4 expression 
both in uroepithelial  and in hematopoietic cells within the bladder was important for defense 
against UTI (75). The identity of the TLR4-expressing hematopoietic cells remained 
unresolved. Possible candidates known to express TLR are MΦ and DC. The current model 
which described the interplay between the host cells and the invading UPEC is shown in 
Scheme 1. UPEC adhere, invade and replicate in uroepithelial cells. Afterwards these infected 
cells can exfoliate and release UPEC into the bladder lumen. NΦG are known to infiltrate the 
uroepithelium to control the infection. The role of DC, MΦ, B- and T-cells and the source of 
several innate effector molecules in this infection are unknown.  
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Scheme 1. Interplay between UPEC and host defense mechanisms 
4.3. Crosstalk between NΦG and mononuclear cells  
NΦG are considered as non antigen-specific leukocytes, involved in the first line of 
defense against infection. Their functions in infection include phagocytosis and secretion of 
preformed enzymes and partially reduced molecules of oxygen. In addition to these direct 
anti-microbial functions, NΦG contribute to the recruitment, activation and programming of 
APC by secreting proinflammatory chemotactic signals that attract monocytes and DC (13). 
TNFα is proposed to be one of the major NΦG-derived chemokines that drive activation and 
differentiation of MΦ and DC (89) . Furthermore, there is cross-talk of NΦG with MΦ 
resulting in the generation of pro- or anti- inflammatory MΦ. Their interaction with DC 
promotes maturation of the latter (7). NΦG also proteolytically cleave prochemerin to 
generate chemerin, one of the few chemokines that attracts both immature DC and pDC (92). 
This activation and differentiation of cells by NΦG is bidirectional. NΦG function and 
activation can be altered by signals from MΦ and DC (20).  
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4.4. DC in UTI 
DC originate from a hematopoietic stem cell precursor and reside in lymphoid and 
non-lymphoid tissues. They are specialized at uptake, transport, processing and presentation 
of antigen to T lymphocytes and represent the most effective inducers of adaptive immunity 
(51). Several murine DC subsets have been identified that differ in surface phenotype, 
activation state and functionality. There are three major DC subtypes: epidermal Langerhans 
cells (LC), plasmacytoid DC (pDC) and conventional DC (cDC) (4, 5, 78) (6). These DC 
subsets can be subdivided by defining their cell surface molecules. Langerin is a characteristic 
molecule for LC whereas B220 defines the pDC subset. CDC can be subdivided into 
CD11b¯ CD8α+ and CD11b+ CD8α¯ DC. CD8α+ DC have been shown to exhibit cross 
presenting ability important for activation of CD8α+ T cells (18). In the blood, the spleen and 
in non-lymphoid tissues, cDC possess a more immature phenotype, characterized by low 
levels of MHC class II and costimulatory molecules, whereas cDC in the lymph nodes have a 
more mature phenotype characterized by high levels of these molecules. As the spleen lacks 
afferent lymphatic vessels, it is likely that the immature cDC in the spleen are blood-derived, 
whereas mature cDC in the lymph node originate at least partially from tissue-derived DC, 
which matured after antigen encounter. In addition to the well-described role of DC as 
inducers of adaptive immune responses, recent studies have proposed a role of DC also in 
innate immunity (68). For example, pDC stimulated antiviral defense by secretion of 
type I interferons (15). In bacterial infections, a newly discovered DC subpopulation, called 
“Tip-DC”, which produce TNFα and iNOS has been reported to be critical in the defense 
against the gram-positive rod Listeria monocytogenes (77). These cells were absent in 
CCR2-deficient mice, and the resulting lack of splenic iNOS- and TNFα-producing cells led 
to susceptibility to these gram-positive bacteria. Although these two mediators are known to 
be generally involved in antibacterial defense, their roles in UTI, as those of CCR2 and of 
Tip-DC are unknown. 
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4.5. Chemokines involved in homeostatic and inflammatory migration of leukocytes  
Chemokines are small proteins that act as activators and chemoattractants for leukocyte 
subpopulations. They comprise one of two groups of chemoattractants, the other one being 
the ‘‘classical’’ chemoattractants, bacterial-derived N-formyl peptides, complement fragment 
peptides C5a and C3a as well as lipid molecules such as leukotriene B4 and platelet-activating 
factors (25, 28, 31, 74). The chemokine superfamily can be divided into 4 groups (CXC, 
CX3C, CC, and C) according to the positioning of the first 2 closely paired and highly 
conserved cysteins of the amino acid sequence (Table 1). Their chemotactic function is 
mediated through a family of 7-transmembrane-spanning G-protein–coupled receptors, the 
chemokine receptors (CCR). 
Receptor Ligands Cellular distribution 
   
CXC chemokines   
CXCR2 GRO (KC), LIX (GCP2), MIP-2 N, M, T, NK, En 
CXCR3 MIG, crg-2 (IP-10); ITAC (CXCL11) act T 
CXCR4 SDF-1 (PBSF) T, B, DC, En 
CXCR5 BLC (BCA-1) B 
      
CC chemokines   
CCR1 MIP-1a, RANTES, MCP-3 N, M, T, NK, B 
CCR2 MCP-1, MCP-3, MCP-5 M, DC 
CCR3 Eotaxin, RANTES, MIP-1a Eo, Bs, T 
CCR4 MDC (ABCD-1), TARC act T, NK T, DC, reg T   
CCR5 RANTES, MIP-1a, MIP-1b T, M, DC 
CCR6 MIP-3a (LARC, Exodus) T, B, DC 
CCR7 SLC (6Ckine), ELC (MIP-3b) T, B, DC 
CCR8 TCA-3 (I-309) M, Thymus 
CCR9 TECK T, Thymus 
      
C chemokine   
XCR1 Lymphotactin (SCM-1) T, B, NK 
      
CX3C chemokine   
CX3CR1 Fraktalkine (neurotactin) act T, NK, M, DC 
act T, activated T cell; B, B-cell; DC, Dendritic cell; En, Endothelial cell; M, monocyte/MΦ 
N, neutrophil; NK, natural killer cell; reg T, regulatory T cell;T, T-cell 
 
Table 1. Chemokines, their ligands and the cellular distribution.  
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Interaction of the chemokine ligand with its receptor causes attraction of various cell types 
into non-inflamed and inflamed tissue. Homeostatic chemokines like fraktalkine induce 
constitutive migration of immune cells into tissue under non-inflammatory conditions, 
whereas inflammatory cytokines like MCP-1 and MIP-2 attract MΦ and NΦG into inflamed 
tissue. In models of bacterial respiratory tract and skin infections, recruitment of leukocytes, 
in particular NΦG, MΦ and DC from the circulation is essential to induce innate immune 
responses in order to control the pathogens (50) (62) (73). The migration of NΦG is critically 
dependent on the chemokine MIP-2 and TNFα. It has been shown that in the absence of 
MIP-2, UTI is aggravated and increased renal scarring was observed (23). Inflammatory MΦ 
and DC express the chemokine receptors CCR1, CCR2 and CCR5 on their surface that enable 
migration into inflamed tissue (91). A role of CCR2 in UTI is supported by a study 
demonstrating the release of the CCR2 ligand, MCP-1 (CCL2), but the contribution of this 
receptor to the defense against UTI is unknown (30). Resident tissue MΦ and DC express the 
fraktalkine receptor CX3CR1 on their surface. Although there is evidence that this receptor 
primarily mediates constitutive cellular migration into non-inflamed tissue, its exact function, 
in particular in inflammation, remains unknown.  
4.6. CX3CR1 mediates DC access to the intestinal lumen  
DC and MΦ are critical in innate and adaptive immunity to the intestinal bacterial 
microbiota (58). DC populating the entire lamina propria of the small intestine were 
previously observed in mice (69) (49). These lamina propria DC were found to be dependent 
on the chemokine receptor CX3CR1 to form transepithelial dendrites and furthermore, these 
protrusions enable DC to sample luminal antigens. CX3CR1+ DC were also found to 
contribute to the clearance of entero-invasive pathogens. (88) (57) (58). 
CX3CR1+ DC have been found also within normal murine kidneys (80). Laser-scanning 
confocal microscopy revealed an extensive, contiguous network of stellate-shaped 
CX3CR1+ DC throughout the interstitial and mesangial spaces of the entire kidney. Intravital 
microscopy of the superficial cortex showed stationary interstitial CX3CR1+ DC that 
continually probed the surrounding tissue environment through dendrite extensions. Flow 
cytometry of renal CX3CR1+ DC showed significant expression of CD11c and F4/80, high 
major histocompatibility complex class II and FcR expression (80). 
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4.7. Mononuclear cells in the circulation arise from BM progenitors 
Mononuclear leukocytes in the circulation develop from BM-derived progenitors, which 
express the characteristic monocyte surface molecules F4/80, CD115 and CD11b (21) (24) 
(82) (66) (29). Most of these monocytes in the BM express high levels of Gr1 (Gr1HI). 
Adoptive transfer experiments showed that Gr1HI monocyte progenitors in the BM gave rise 
to Gr1HI monocytes in the blood, but not to the Gr1LO subset (24). However, more recent 
studies showed a potential of the Gr1HI monocyte subset in the BM to give rise to 
Gr1LO monocytes in the blood and to LC (26) (21). A short time before ending this thesis, it 
has been shown that CCR2 may contribute to the emigration of monocytes from the BM into 
the circulation (76). In support of this, CCR2-deficient mice showed increased numbers of 
CCR2HI Gr1HI monocytes in the BM under infectious conditions, whereas the number of these 
monocytes in the circulation was diminished (76).  
4.8. Blood monocytes consist of two different subsets: CX3CR1+ and CCR2+ 
Peripheral blood monocytes are a heterogeneous cell population and represent about 
5 to 10% of blood leukocytes. Two main subsets of monocytes, defined by different 
expression levels of CCR2, CX3CR1 and Gr1 have been described in mice and humans (24) 
(21). CX3CR1LO Gr1HI monocytes are large granular mononuclear cells of 10 to 14 µm 
diameter, while CX3CR1HI Gr1LO cells are smaller mononuclear cells with a diameter of 
8 to 12 µm (24). The CX3CR1HI CCR2LO Gr1LO subset is thought to be primarily recruited 
into non-inflamed tissue, whereas CCR2HI CX3CR1LO Gr1HI blood monocytes are actively 
recruited into inflamed tissue, e.g. inflamed skin or peritoneum (24) (82), the inflamed retina 
(93) and infection with Toxoplasma gondii (70) or Listeria monocytogenes (82). In many 
models of acute inflammation, Gr1HI monocyte recruitment was critically dependent on CCR2 
(10) (53), but not on CX3CR1 (38), but a crucial role of CX3CR1 in constitutive migration 
into non-inflamed tissue is unknown. 
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It has been shown that both monocyte subsets can be depleted by intravenous 
administration of clo-lip into mice (84) (Fig. 1). Interestingly, the CCR2+ Gr1HI monocyte 
subset reconstituted the circulation already 24 hours after depletion, whereas the CX3CR1+ 
Gr1LO remained absent for at least two days. 
 
Fig. 1. Circulating monocytes after depletion (from (84)) 
4.9. Migratory fate of monocytes and their function as progenitors  
Blood monocytes are thought to represent precursors for peripheral MΦ and DC (24). 
Once they emigrate across endothelial barriers, they differentiate into these different 
phagocyte phenotypes. The murine CX3CR1LO Gr1HI subset was termed “inflammatory 
monocyte” and represents circulating immediate precursors for antigen-presenting DC and 
CD11c- myeloid cells under inflammatory conditions. Furthermore, it has recently been 
shown that circulating Gr1HI monocytes give rise to the afore mentioned Tip-DC (76). 
Although stringent evidence is lacking, the CX3CR1HI Gr1LO murine subset has been termed 
“resident monocyte” and was proposed to represent a circulating precursor population which 
constitutively migrates into non-inflamed tissue. DC with innate immune functions (19) (77) 
have recently been shown to arise from Gr1HI monocytes (76). There is no experimental 
evidence that the other CX3CR1HI Gr1LO monocyte subset persisted longer in tissues and 
served as a precursor for resident myeloid cells in non-inflamed tissue (24). Less is known 
about the trafficking and fate of Gr1LO monocytes under inflammatory and non-inflammatory 
conditions. In contrast to Gr1HI monocytes, the Gr1LO counterpart rarely migrated into 
inflamed tissue, including the acutely inflamed peritoneum (24) (82) or the skin after 
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intracutaneous injection of Latex (Lx) beads (66), administration of vaccine formulations (45) 
or epicutaneous UV exposure (26). It has therefore been hypothesized that Gr1LO monocytes 
may fulfill critical roles in replacing resident MΦ or DC in the steady state (24). Given their 
higher surface expression of CX3CR1 and the CX3CL1-dependent transendothelial migration 
of human CD16+ monocytes in vitro (1) (24), it has further been suggested that the chemokine 
receptor CX3CR1 on Gr1LO monocytes is crucial for migration into non-inflamed tissue aimed 
at replacing resident MΦ or DC. However, the experimental evidence for the trafficking 
pattern and the potential role of Gr1LO monocytes as precursors for resident tissue cells is 
poor. After adoptive transfer, Gr1LO monocytes could be found in blood, spleen, liver, lung 
and brain of recipients for up to three days after transfer, and then at very diminished numbers 
by day 4 (24), but whether these adoptively transferred monocytes gave rise to DC is 
unknown. 
Compelling experimental in vivo evidence for the ability of monocytes and MΦ to convert 
into DC is poor. After intradermal injection of fluorescently labeled Lx beads into the skin, 
mild inflammation is observed followed by the recruitment of phagocytic CD11b+ monocytes. 
About 25% of these Lx-bearing monocytes migrated into the draining LN where they 
differentiated into MHCII+DEC205+ DC that expressed CD11c (67) (71). Surprisingly, 
neither CCR2 nor CX3CR1 were essential for monocyte recruitment, migration or 
differentiation towards DC in this model (2). Gr1LO monocytes were not recruited at all in this 
model, but Gr1HI and a third minor subset of Gr1INT expressing monocytes, which appeared to 
represent the population that gave rise to DC. Furthermore, these cells expressed mRNA for 
CCR7 and CCR8, which are known to regulate the ability of DC to migrate into lymph nodes 
(66). It is clear that monocytes can give rise to DC under inflammatory conditions, but the 
turnover of DC in the steady state remains unresolved. Recently, a clonogenic BM progenitor 
that is CD117+ (c-kit), CD115+ and CX3CR1+ has been identified that gave rise to monocytes, 
MΦ and resident CD8α+ spleen DC, which represent the DC subpopulation capable of cross-
presentation (21). Direct evidence that a circulating monocyte subset gives rise to a resident 
peripheral DC population, was only provided for the differentiation of Gr1HI monocytes into 
epidermal LC (26), but experimental evidence for the Gr1LO subset to do so is limited.  
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In the steady state, LC arise from a local precursor (53), which was dependent on CD115 
expression (26). However, severe skin inflammation induced by local UV irradiation results 
in the full depletion of LC from skin, apparently including loss of the local precursor (53).    
In this setting, Gr1HI, but not Gr1LO monocytes were recruited to the inflamed skin in a 
CCR2- and CCR6-dependent manner, proliferated locally and differentiated into functional 
LC or dermal MΦ in vivo (53) (52) (26). This work revealed the differentiation potential of 
monocytes and showed how they fulfilled their predicted role as circulating precursors for DC 
and MΦ, especially during inflammatory conditions, in which there is increased demand for 
DC and MΦ. Similarly, in the context of vaccination through skin and other mucosal routes, 
Gr1HI monocytes appear to be the most relevant precursors for cross-priming DC that initiate 
CD8α+ T cell responses.  
Monocyte progenitors also contributed to the generation of DC with innate immune 
functions in infection models. In the spleen, Gr1HI monocytes have been linked to the 
formation of Tip-DC. Another interesting role for Gr1HI monocytes in the context of 
immunization is the ‘‘priming’’ of naive B cells that will ultimately facilitate their 
differentiation into Ig-producing cells. This process was recently found to be dependent on 
Gr1HI  monocytes (37). Interestingly, these cells appeared to serve as the source for IL-4 that 
in turn triggered B cell priming (37). 
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4.10. Signals in the BM maintain the homeostasis of circulating leukocytes 
Although several adhesion molecules and chemokines have been studied in the process of 
emigration from the BM, the underlying molecular mechanisms are not well understood. The 
chemokine SDF-1 has been shown to contribute to homing of progenitor cells to the BM (44). 
This chemokine was constitutively expressed on stromal cells (9, 56) and signaling to the 
receptor CXCR4 activated cell surface integrins (61). This interaction was essential for 
retention of precursor cells in the BM (72), whereas the lack leads to emigration of leukocytes 
out of the BM. Furthermore, very recent investigation by others have shown a contribution of 
CCR2 in the egress of BM progenitors into the circulation (76) (Scheme 2).  
Monocytes, which are generated in the BM, are released into the circulating leukocyte pool 
(24). Expression of MCP-1, the ligand for CCR2 on these monocytes, is associated with 
migration of monocytes into inflamed tissue and therefore with immune defense against 
microbial pathogens (Scheme 2). CCR2-deficient mice showed increased susceptibilities to 
various pathogens, like Listeria monocytogenes (77) and diminished recruitment of 
monocytes to the site of infection (42). Although several studies showed expression of the 
CCR2 ligand MCP-1 in the bladder, the role of CCR2 in the recruitment of immune cells into 
non-infected and infected bladders remains unknown (87). Furthermore, signals that mediate 
and maintain homeostasis of monocytes in infected and non-infected mice are poorly 
understood (16). 
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Scheme 2. Monocyte subsets arise from a BM progenitor 
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5. AIMS OF THIS STUDY 
The aim of the present study was to elucidate the recruitment mechanisms and the 
functionality of phagocytes in UTI, using a murine model of this infection facilitated by 
transurethral instillation of UPEC. In particular, the following specific questions were 
addressed: 
1. Are DC recruited to the bladder under homeostasis and infectious conditions? 
2. What is the role of DC, in particular Tip-DC in UTI, and which molecular mechanisms 
mediate their recruitment and their functionality in the bladder? 
3. Are the composition and the number of MΦ and monocytes in organs involved in UTI, 
like the BM, the blood and the bladder changed? 
4. Which molecular mechanism mediates the migration of MΦ, in particular of Gr1LO and 
Gr1HI MΦ under homeostasis and infectious conditions? 
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6. MATERIAL AND METHODS 
6.1. Solutions, Media and Supplements 
Red blood cell removal buffer (RCB) was prepared by dissolving 15.58g NH4Cl (0.146 M), 
0.074g ethylenediaminetetra-acetic acid (EDTA)-disodium salt, 2.0g NaHCO3 in 2 litres of 
Milli Q water. The solution was autoclaved and the final pH of 7.3 was adjusted.  
 
FACS buffer consisted of PBS containing 0.1% BSA and 0.1% NaN3. 
 
Wash buffer for the digested bladder cell suspensions consisted of HBSS without Ca2+ and 
Mg2+, 10mM EDTA, 20mM Hepes and 0.5% BSA. 
 
Wash buffer for BM cells consisted of DMEM, 5mM EDTA and 0.5% BSA. 
 
Hanks complete consisted of HBSS containing 0.1% BSA and 5 mM EDTA 
 
Foetal Calf Serum (FCS) was heat-inactivated by immersing in a 56°C waterbath for 30 
minutes. The heat inactivated FCS was aliquoted and stored at -20°C. 
 
Nylon mesh (30µm, 50µm, 100µm) to filtrate cell suspension was cut into small square 
pieces and autoclaved. 
6.2. Mice and reagents 
All mice used had been backcrossed >10 times to a C57BL/6 background and were bred 
and kept under SPF conditions. CCR2-/- ApoE-/- double knockout mice were kindly provided 
by C. Weber (Aachen, Germany) (14, 32), and crossed with C57BL/6 mice to yield 
CCR2-single knockout mice in the F2 generation. CD11c-DTR mice (10) expressing GFP and 
the diphtheria toxin receptor (DTR) on CD11c+ cells had been backcrossed 10 times to the 
C57BL/6 background. To deplete DC, 4 ng diphtheria toxin per gram body weight was 
injected i.p. 72 hours and 24 hours before infection. CX3CR1-deficient mice were kindly 
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provided by F. Geissmann (Paris, France) and D. Fogg (Paris, France). By replacing the 
CX3CR1 allele, heterozygous and homozygous mice harbor green CX3CR1 positive cells. 
Animal experiments had been approved by a local animal ethics reviewing board.  
6.3. UPEC and UTI model 
The UPEC strain 536 (O6:K15:H31) originated from a UTI patient (8) (12). The 
chromosomal integration of GFP into this UPEC strain was done by Dr. Ulrich Dobrindt, 
Würzburg. Tagging of E. coli 536 with a stable fluorescence marker was achieved by λ Red 
recombinase-mediated chromosomal insertion of a Ptetp/o::gfpmut3.1 fusion into the attB site 
of the bacteriophage λ (17). The promoterless gfpmut3.1 gene was amplified from 
pGFPmut3.1 (Clontech) by PCR using primers gfpfus1 (5'-GAATTAAA-
GAGGAGAAATTAAG-3') and gfpfus2 (5'-CGCGGCAGCAAACGCCAGCCTGGCG-
ATTCTCGAATCTGGCGACTGGCAGCGACTAGTAGGTCAGCTAATTAAGC-3'). The 
98-bp tetp/o region was amplified from pASK75 (37) with primers tetfus1 (5'-
TGAAATAGAAAAATGAATCCGTTGAAGCCTGCTTTTTTATACTAACTTGACCATC
GAATGGCCAGATG-3') and tetfus2 (5'- CTTAATTTCTCCTCTTTAATATTTCACTTTT-
CTCTATCACTGATAG-3'). Both PCR products were fused in a recombinant PCR with the 
primers tetfus1 and gfpfus2. The PCR resulted in amplification of an 850-bp Ptetp/o:gfpmut3.1 
DNA fragment with flanking 50-bp overhangs homologous to the chromosomal 
bacteriophage λ attachment site attB which was subsequently cloned into pGEM-T Easy 
(Promega, Mannheim, Germany). This plasmid was used as template for further amplification 
of the 850-bp PCR fragment flanked by 50-bp overhangs homologous to the λ attB site with 
the primer pair tetfus1 and gfpfus2. The resulting PCR product was electroporated into E. coli 
536/pKD46. Fluorescent derivatives of strain 536 with a chromosomally inserted 
Ptetp/o:gfpmut3.1 fusion were then selected using a Typhoon™ 8600 Variable Mode Imager 
(Molecular Dynamics; Krefeld, Germany). 
To induce UTI, UPEC were grown overnight in LB medium, then harvested by 
centrifugation at 1200 g for 20´ and resuspended in PBS to a concentration of 1x1010 colony 
forming units (CFU) per mL. Anesthetized female mice of 8 to 10 wks of age were infected 
by transurethral inoculation of 5x108 E.coli 536 (0.05 mL) into the bladder using a soft 
polyethylene catheter (outer diameter 0.6 mm; BD, Heidelberg, Germany) (27) (54). To 
determine the bacterial load, the bladders were rinsed extensively with PBS in situ, then 
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removed under sterile conditions and homogenized mechanically. The number of bacteria was 
quantified by scoring CFU after overnight culture at 37°C on CPS ID plates (Biomerieux, 
Nürtingen, Germany). 
6.4. Immunohistochemistry and electron microscopy 
For immunohistology, organs were fixed with 0.1 M Tris pH 7.4, 0.05% Zinc-Acetate, 
0.5 % Zinc-Chloride and embedded in steedman's wax (81). Blocks were cut into 5 µm 
sections and mounted on poly-L-lysin-coated glass slides. For identification of CD11c+ cells, 
biotinylated anti-CD11c (clone HL-3, Pharmingen, Heidelberg, Germany) or isotype controls 
were used, revealed with Vectastain ABC kit (Vector Laboratories, Burlingame, CA) and 
3,3'-diaminobenzidine (DAB) and counterstained with methyl green. For 
immunofluorescence, antibodies were revealed with Streptavidine-Alexa568 and 
counterstained with Hoechst 33258 (Molecular Probes, Karlsruhe, Germany). 
For electron microscopy, bladder tissue was fixed with 3% glutaraldehyde in 
0.1 M cacodylate buffer (pH 7.4) followed by 2 % osmiumtetroxide (OsO4). Tissues were 
embedded in epoxon 812 (Serva, Heidelberg, Germany) and 40-50 nm sections were cut with 
an LKB ultramicrotome UM IV (Leika, Frankfurt/Main, Germany) and analyzed using a 
CM10 Electron microscope (Philips, Hamburg, Germany). 
6.5. Isolation and analysis of leukocytes from the bladder 
A protocol for DC isolation from the kidney (41) was adapted for application to bladder 
tissue. Briefly, bladders were sliced with a scalpel and digested for 30 min at 37°C with 
0,5 mg/mL collagenase (Sigma Aldrich, Taufkirchen, Germany) and 100 µg/mL DNAse I 
(Sigma Aldrich, Taufkirchen, Germany) in RPMI 1640 medium (Invitrogen, Karlsruhe, 
Germany) containing 0.5% FCS (PAA Laboratories, Pasching, Austria) and 20 mM HEPES. 
Cell suspensions were filtered through 100 µm nylon mesh and washed with HBSS without 
Ca2+ and Mg2+ containing 10 mM EDTA, 0.1% BSA and 20 mM HEPES. The number of 
viable cells was determined by trypan blue staining.  
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6.6. Isolation and analysis of leukocytes from the blood and BM 
Whole blood was subjected to red cell lysis using RCB and washed twice in DMEM 
(Invitrogen, Karlsruhe, Germany) containing 5 mM EDTA and 0.5% BSA. Cells were washed 
in HBSS (Invitrogen, Karlsruhe, Germany) containing 0.02% NaN3 and 2 mM EDTA and 
2% FCS. 
BM cells were obtained by flushing the femur with HBSS containing 0.1% BSA and 5 mM 
EDTA followed by red blood lysis and two washing steps in HBSS (Invitrogen, Karlsruhe, 
Germany).  
6.7. Depletion of monocytes 
Clodronate or PBS was incorporated into liposomes as described previously (90) and blood 
monocytes were eliminated with these liposomes by i.v. injection of 0.25 ml into the lateral 
tail vein (82). Control liposomes that incorporated PBS instead of clodronate were used, but 
without affecting total monocytes or subpopulations.  
6.8. Labeling of blood monocytes 
0.5-µm FITC-conjugated (yellow gold) plain microspheres (2.5% solids; Polysciences Inc., 
Heidelberg, Germany) were diluted 1:25 in PBS, and 250 µl of the solution was injected into 
the lateral tail vein for labeling of Gr1LO monocytes. To label Gr1HI monocytes, 250 µl of 
liposomes containing clodronate were i.v. injected followed by 250 µl of fluorescent 
microspheres i.v. 16–18 hours later. Blood monocytes were fully depleted by clo-lip 
administration (82), but splenic and liver MΦ are also eliminate (90). Other MΦ populations 
are protected because clo-lip will not cross vascular barriers (90).  
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6.9. Flow cytometrical analysis 
Fc receptors were always blocked with 24G2 culture supernatant or with a combination of 
human, mouse and rabbit serum. Titrated amounts of the following labeled antibodies from 
Pharmingen (Heidelberg, Germany) were used for staining of 1x106 cell samples: anti MHC 
class II-FITC (25-9-3), anti iNOS-FITC (BD6), anti-TNFα APC, anti CD80-biotin 
(16-10A1), anti CD86-FITC (GL1), anti CD40-APC (3/23), anti CD11b-PerCp-Cy5.5 
(M1/70), anti Gr1-PE/Cy7 (RB6-8C5) and anti CD11c-APC (HL-3). Anti F4/80-biotin 
(CI:A3-1) and MIP-2 biotin (AAM48B) was from Serotec (Düsseldorf, Germany), CD115 PE 
(AFS98) was from eBioscience (San Diego, USA) and anti CCR2 (MC21) was kindly 
provided by Dr. M. Mack, Regensburg, Germany (47). Cells were analyzed on a LSR II 
cytometer (BD, Heidelberg, Germany) using Flow Jo software (Tristar, Phoenix, AR, USA). 
Forward and side scatter gating was adapted to include MΦ and NΦG. The abundance of 
different cell populations was calculated by adding 10µm PerCP-Cy5.5- or APC-labeled 
microbeads (BD, Heidelberg, Germany) into the tubes. 
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7. RESULTS 
7.1. Different leukocytes are recruited into the bladder after infection  
To study the role of immune cell subsets in UTI, UPEC were transurethrally instilled into 
the bladders of C57BL/6 mice. To quantitatively assess the extent of infection, the number of 
bacterial colony forming units (CFU) in the bladder was determined. After instillation of 
5x108 UPEC into the bladder, number of CFU decreased rapidly and 3 days after infection 
only few bacteria remained detectable in the bladder (Fig. 2A).  
To correlate the bacterial load with the extent of vesical leukocyte infiltration, the number 
of F4/80+ CD11c – MΦ, of Gr1+ CD11c - F4/80 - MHC class II – NΦG and of CD11c+ DC in 
the bladder were determined by adding standardized numbers of Lx particles into the 
analyzing tubes (Fig. 2 and Table 2). This staining protocol for these different cell types was 
chosen to avoid inclusion of F4/80+ CD11c+ DC (41) into the MΦ count, and to prevent 
inclusion of Gr1+ F4/80+ monocytes (24) or CD11c+ Gr1+ MHC II+ pDC (15) into the NΦG 
count. In non-infected animals, very few leukocytes were detectable. Already 2 hours after 
infection numbers of MΦ, NΦG and DC had increased significantly. The numbers of all 
leukocyte subsets peaked 14 hours after infection, whereas NΦG was the most abundant cell 
subset. Numbers of all leukocyte populations were reduced already after 3 days. Number of 
NΦG had decreased greatly after 3 days, whereas DC and MΦ remained elevated (Fig. 2 and 
Table 2).  
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Fig. 2. Kinetics of bacterial clearance and leukocyte infiltration in UTI. 
C57BL/6 mice were injected transurethrally with 5x108 E.coli 536. At various time points, bladders 
were rinsed extensively with PBS in situ and removed for analysis. To determine the bacterial load, 
the bladders were mechanically homogenized. Aliquots were dispersed on CPS plates and 
incubated at 37°C. CFU of UPEC on the plates were counted after 14 hours. For the time point of 
infection, the number of instilled UPEC was given (A). 
To determine the number of infiltrating leukocytes, bladders were digested with collagenase, 
filtered on 100 µm mesh, Fc receptors were blocked and cells were stained for flow cytometrical 
analysis. The numbers of CD11c+ DC (●), F4/80+ CD11c─ MΦ (♦) and Gr1+ CD11c─ F4/80─ MHC 
class II─ NΦG (○) were determined by adding standardized numbers of Lx particles to the 
analyzing tubes. Dead cells were excluded using Hoechst 33258 (B).  
Data are representative for >5 individual experiments. Given are mean ± SD in groups of 5 mice.  
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Time after infection  DC MΦ NΦG 
0 h 144 ± 36 109 ± 34 41 ± 26 
2 h 323 ± 75 149 ± 27 1053 ± 700 
14 h 2845 ± 976 4035 ± 586 17096 ± 6625 
24 h 1199 ± 296 2408 ± 471 9001 ± 1310 
48 h 1255 ± 144 1928 ± 453 2126 ± 1061 
72 h 1311 ± 83 1822 ± 502 1622 ± 87 
Table 2. Number of DC, MΦ and NΦG in the bladder  
7.2. Infection of epithelial cells and recruitment of leukocytes into the bladder 
The mechanism of adhesion and invasion of UPEC and the infiltration of mono- and 
polymorphonuclear leukocytes were further characterized by electron microscopy (EM) (Fig. 
3). We detected adhesion (Fig. 3A) and invasion of instilled UPEC (Fig. 3B) into 
uroepithelial cells. Infected cells showed pod like structures on their surface demonstrating 
bacteria embedded in a fibrous matrix (Fig. 3B). Each bacterium was surrounded by an 
electron-lucent halo separating the bacteria from each other and disconnecting the bacteria 
from the epithelial cell content (Fig. 3B). Infection of uroepithelial cells also induce 
production of mucus to protect cells from infection (Fig. 3A and E). These data suggested that 
this bacterial factory is tightly packed into biofilm-like pod structures in uroepithelial cells, 
which enable persistence of this UPEC strain, as recently reported by others (3). 
EM also revealed infiltrating mono- and polymorphnuclear leukocytes in the bladder, 
which were mostly infiltrating the epithelium (Fig. 3C and F). Intraepithelial NΦG form a 
barrier underneath infected uroepithelial cells and underwent apoptosis (Fig. 3A, B and D). 
We locally found close contact of apoptotic NΦG and infiltrating mononuclear cells in the 
submucosa, but not in the epithelium (Fig. 3D). These mononuclear leukocytes showed 
typical lysosomes, which is one characteristic feature of tissue MΦ. Furthermore, we found 
intraepithelial mononuclear leukocytes in the epithelium and bladder submucosa (Fig. 
3F and G), which contained neither the segmented nuclei of NΦG, nor large lysosomes 
typical of MΦ. These cells showed abundant perinuclear organelles and protrusions devoid of 
organelles (Fig. 3E and G) and were compatible with those of DC in non-lymphoid tissue 
(40).  
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Fig. 3. EM of infected bladders.  
C57BL/6 mice were infected transurethrally with 5x108 E.coli 536. After 24 hours, sections of the 
bladder were analyzed by electron microscopy. The images are representative for more than 
5 mice analyzed. The bars in the lower right corners indicate 20µm (A,C,E), 5µm (D,F) or 
30µm (B). 
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7.3. DC are recruited into the epithelium after infection 
This infiltrating cell subset, which showed typical characteristics of DC, was further 
analyzed in infected and non-infected bladders by immunohistochemistry (IHC) and 
immunofluorescence (IF) (Fig. 4). To this end, bladder sections were stained for the murine 
DC marker CD11c. This approach demonstrated CD11c+ mononuclear leukocytes with 
dendritic morphology in the uroepithelium and bladder submucosa (Fig. 4B and C). These 
vesical leukocytes were absent from the bladders of non-infected mice (Fig. 4A). We also 
found that infiltrating DC were in close contact to instilled E.coli 536gfp and furthermore had 
taken up UPEC (Fig. 4D). 
 
 
Fig. 4. Recruitment of DC to the bladder.  
C57BL/6 mice were infected transurethrally with 5x108 E.coli 536. After 24 hours, sections of the 
bladder were stained for CD11c and analyzed by immunohistochemistry (A, B) and 
immunofluorescence (C, D). CD11c+ cells were brown (A, B) or red (C, D). Counterstaining was 
performed with methyl green (A, B) or Hoechst 33258 (C, D). Inoculated E.coli 536gfp were green 
(D). The images are representative for more than 10 mice analyzed. The bars in the lower right 
corners indicate 20µm. 
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7.3.1. Characterization of DC infiltrating the bladder  
To further characterize the DC infiltrating the bladder, expression of activation and 
maturation markers was determined. The few vesical DC in non-infected control mice 
expressed low or intermediate levels of CD40, CD80, CD86 and MHC class II. All 
costimulatory molecules and MHC II were markedly upregulated 24 hours after infection 
(Fig. 5A), indicating DC maturation. For CD80 and MHC class II, a DC subpopulation devoid 
of surface expression of these molecules were evident in infected mice, which may represent 
immature DC recruited from the circulation. Neither in the spleen, nor in subcutaneous lymph 
nodes, activated DC were detectable after infection, indicating that UPEC had not spread 
systemically. 
Next, the subtype of infiltrating DC was determined. The few DC in non-infected bladders 
expressed F4/80 and CD11b (Fig. 5B, Table 3). One day after infection, only some DC 
devoid of these markers were detectable, while most were of the CD11b+ phenotype (Fig. 5B, 
Table 3). DC expressing CD8α, Gr1 or B220 were absent, indicating that neither pDC nor 
CD8α+ were recruited in UTI (Fig. 5B, Table 3). In addition to DC, F4/80+ CD11c─ MΦ and 
Gr1+ CD11c─ F4/80─ NΦG were evident (Fig. 5B, Table 3).  
Closer examination of the CD11b+ DC from infected mice revealed DC that expressed 
intermediate (see area Fig. 5B, 2nd row, 1st column) levels of CD11b. These CD11bINT DC 
were rare in the bladders of non-infected mice (Fig. 5B).  
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Fig. 5. Characterization of vesical DC in UTI. 
C57BL/6 mice were infected with 5x108 E.coli 536. After 24 hours, vesical DC were isolated and 
expression of surface molecules was determined. 
Expression profiles in non-infected (grey area) versus infected mice (transparent area with thick 
line) were overlaid in histograms. Numbers indicate the mean fluorescence intensity (MFI) of these 
two cell populations (A). 
Viable DC from infected and non-infected mice were stained for the DC subtype markers CD11b, 
F4/80, Gr1 and CD8α and analyzed by flow cytometry. Numbers indicate the cellular proportions in 
each quadrant. The area in the lower left dot-plot indicates CD11bINT DC (B).  
Data are representative for >5 (A, B) individual experiments. 
 
Time after infection      Non-infected      Infected 
CD11bLO/HI    DC 98 ± 13 821 ± 91 
CD11bINT DC 0 ± 0 422 ± 21 
F4/80+ DC 61 ± 13 621 ± 78 
Gr1+ “plasmacytoid” DC 0 ± 0 2 ± 0.2 
CD8α+ DC 0 ± 0 9 ± 1 
Table 3. Numbers of different DC subtypes 24 hours after infection 
C57BL/6 mice were infected with 5x108 E.coli 536. After 24 hours, vesical DC were isolated by 
collagenase digestion and calculated by adding standardized numbers of beads to the samples.  
Data are representative for >6 individual experiments. Given are mean ± SD in groups of 5 mice. 
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7.3.2. TNFα/iNOS-producing (Tip-) DC are recruited to the bladder in UTI 
DC expressing intermediate levels of CD11b (CD11bINT) and producing TNFα and iNOS 
(Tip-DC) have recently been shown to be critical in the innate defense against bacterial 
Listeria monocytogenes infection (77). We aimed to determine whether the vesical CD11bINT 
DC population identified in UTI (Fig. 5B) matched the criteria of Tip-DC and wether they 
exert different functionality than the conventional DC (cDC), which expressed high or low 
levels of CD11b (CD11bLO/HI). Indeed, about 8-15 % of the vesical DC expressed iNOS, in 
contrast to less than 0.1% in non-infected bladders (Fig. 6). TNFα was produced by about 
20-30 % of the vesical DC, in contrast to less than 0.1% in non-infected bladders (Fig. 6A). 
All iNOS+ - and TNFα+ DC (Fig. 6B) expressed intermediate levels of CD11b, as described 
for Tip-DC (77). All cDC in UTI neither expressed TNFα nor iNOS.  
Another characteristic of Tip-DC was their absence from CCR2-deficient mice and indeed, 
these mice lacked Tip-DC. (Fig. 6A). All DC in UTI expressed CCR2 (Fig. 6C), implying that 
Tip-DC and cDC must have been positive for this chemokine receptor. Finally, as opposed to 
Tip-DC and in contrast to cDC, these cells did not take up UPEC-derived antigens (Fig. 6D), 
consistent with the previous demonstration that Tip-DC were not involved in adaptive 
immune responses against bacterial pathogens (77). 
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Fig. 6. TNFα/iNOS-producing (Tip-) DC are recruited to the bladder in UTI.  
C57BL/6 or CCR2-deficient mice were infected transurethrally with 5x108 E.coli 536 or 
E.coli 536gfp. After 24 hours, the bladders of infected mice and non-infected controls were 
digested with collagenase and analyzed for surface and intracellular molecules.  
Cells isolated from infected and non-infected controls were stained for CD11c and for intracellular 
expression of iNOS and TNFα (A). 
Vesical DC from infected mice were analyzed for CD11b (B) and CCR2 (C) expression. The thick 
line indicates expression by Tip-DC, the thin line that of cDC. Grey areas represent isotype 
controls. 
C57BL/6 mice were infected with 5x108 E.coli 536gfp. After 24 hours, vesical DC were isolated and 
fluorescence uptake was determined on Tip-DC (thick line) and cDC (thin line). The grey area 
shows background fluorescence after infection with non-fluorescent UPEC (D). 
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In summary, cDC and Tip-DC differed in phenotype and function. Tip-DC exerted innate 
immune functions like secretion of effector functions, whereas cDC were professional in 
taking up bacteria to induce adaptive immune responses (Table 4).  
   
TNFα and iNOS 
producing DC Conventional DC 
  
    
 Tip-DC cDC 
      
Gr1  –  – 
CD11c  ++  ++ 
F4/80   +  + or – 
CD11b  INT  HI or LO 
CD115  –  – 
      
   
TNFα  +  – 
iNOS   +  – 
UPEC uptake  +  ++ 
MHC class II  +  ++ 
CD80  +  ++ 
      
Table 4. Phenotype and function of cDC and Tip-DC. 
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7.3.3. Crucial role of CCR2 for the recruitment of MHC class II positive DC  
In CCR2-deficient mice, DC numbers were found to be reduced to about 50% (Fig. 7A, B). 
This could not be explained by the absence of Tip-DC, as this population never constituted 
more than 15% of the vesical DC (Fig. 6A, C). Instead, this reduction was due to the selective 
absence of MHC class II+ DC in CCR2-deficient mice (Fig. 7A, B). Interestingly, also 
MHC class II+ non-DC were absent, consistent with previous findings that recruitment of MΦ 
to sites of infection depended on CCR2 (73) (50) (62). DC devoid of MHC II surface 
expression were not significantly altered in CCR2-deficient mice (Fig. 7A, B, C), indicating 
that immature DC use other receptors than CCR2 to migrate into infected bladders. Likewise, 
NΦG numbers were unchanged (Fig. 7C), consistent with previous reports showing 
recruitment of these cells by molecules other than CCR2.  
      
Fig. 7. CCR2 is required for the accumulation of mature DC in UTI. 
C57BL/6 or CCR2-deficient mice were infected with 5x108 E.coli 536. After 24 hours, vesical cells 
were analyzed for expression of MHC class II. Numbers indicate the cellular proportions in each 
quadrant. Shown in B and C are the mean ± SD of groups of 5 mice. Results are representative of 
three individual experiments. 
The numbers of MHC class II─ DC (hatched bars) and those of MHC class II+ DC (white bars) in 
single cell suspensions from the bladder were determined by flow cytometry. Both areas were 
stacked to yield the total numbers of DC (B). 
In the same experiment, numbers of Gr1+ F4/80─ MHC class II─ NΦG were determined (C).  
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7.3.4. CCR2-dependent maturation after phagocytosis of UPEC  
DC are important contributors in induction of adaptive immunity and in phagocytosis of 
antigen. As shown in Fig. 6D, cDC are able to phagocytose inoculated UPEC very efficiently 
and 40 to 66% of these DC were positive for instilled bacteria (Fig. 8). Neither DC in the 
spleen, nor in subcutaneous LN contained GFP-expressing UPEC or had upregulated 
activation markers, indicating that UPEC had not spread systemically. DC expressing 
MHC class II and CD80 contained UPEC (Fig. 8), indicating a correlation of phagocytosis of 
UPEC with these two molecules on DC. In CCR2-deficient mice, the number of these cells 
containing UPEC was reduced to about 30-35%, consistent with the reduced abundance of 
MHC class II+ DC in the absence of this CCR (Fig. 8). The remaining DC presumably used 
molecules other than CCR2 for recruitment to the bladder. These data demonstrated that 
CCR2 contributed to the abundance of mature DC and phagocytosis of UPEC. 
 
Fig. 8. DC expressing MHC II and costimulatory molecules phagocytose UPEC 
C57BL/6 and CCR2-deficient mice were infected with 5x108 E.coli 536 or E.coli 536gfp. After 
14 hours, bladders were digested with collagenase, and viable CD11c-gated cells were analyzed 
for expression of MHC II, CD80 and for uptake of UPECgfp. Numbers indicate the cellular 
proportions in each quadrant. Results are representative for at least 3 experiments with 3 mice per 
group. 
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7.3.5. Neither DC, nor CCR2-dependent cells are required for clearance of UPEC 
To investigate the requirement of Tip-DC for the defense against UTI, UPEC clearance 
from CCR2-deficient mice were determined. These mice cleared infection as efficiently as 
wild type controls (Fig. 9A), implying that Tip-DC were dispensable for bacterial clearance 
from the bladder in UTI.  
To directly address the requirement of DC for the clearance of UPEC, CD11c-DTR mice 
that expressed the DTR under the influence of the CD11c promoter in DC were infected (39). 
Intraperitoneal injection of diptheria toxin resulted in depletion of more than 95 % of DC in 
the circulation and of about 90 % in the bladder (Fig. 9B). The number of NΦG was not 
diminished, at least not to a statistically significant extent (Fig. 9B). Bacterial clearance in 
DC-depleted CD11c-DTR mice was not different from that in non-depleted controls (Fig. 
9A), indicating that DC were dispensable for innate clearance of instilled UPEC. 
 
Fig. 9. Neither CD11c+, nor other CCR2-dependent cells are required for clearance 
of UPEC in UTI. 
CD11c-DTR mice (■), CCR2-deficient mice (▼) and C57BL/6 wild-type controls (●) were infected 
transurethrally with 5x108 E.coli 536. At various time points, numbers of CFU per bladder were 
determined. Bladder weight did not significantly differ 72 hours after infection (wildtype 20.4±1.8 
mg, CCR2-deficient 21.2±1.7 mg) (A). 
Numbers of CD11c+ DC (■, ●) and those of Gr1+ F4/80─ MHC class II─ NΦG (□, ○) in DT-treated 
CD11c-DTR/GFP mice (■, □) and in wild-type controls (●, ○) are given as mean ± SD of groups of 
5 mice (B). Results are representative of four individual experiments. 
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7.3.6. CCR2-independent immune effector cells overlooked Tip-DC functionality  
To elucidate the discrepancy between the requirement of Tip-DC in listeriosis and UTI, 
investigations were performed to determine whether other immune effectors may have 
substituted for the absence of Tip-DC. Indeed, the bladders of CCR2-deficient mice contained 
abundant TNFα− and iNOS producing CD11c─ cells. These cells represented about 85 % of 
the total number of vesical iNOS+ cells and 65 % of the total number of vesical TNFα+ cells 
in wild-type mice with UTI. These data reported above indicated that the loss of Tip-DC in 
CCR2-deficient animals caused a minor decrease (Fig. 10A and B) of both innate effector 
molecules. Given that iNOS-and TNFα producing non-DC expressed CD11b and Gr1, these 
cells represented NΦG and/or MΦ. 
 
Fig. 10. CCR2-independent immune effector cells replace the functionality of Tip-
DC in UTI. 
C57BL/6 or CCR2-deficient mice were infected with 5x108 E.coli 536. After 24 hours, the bladders 
of infected mice and non-infected controls were digested with collagenase and stained for surface 
molecules. Shown are the mean ± SD of groups of 5 mice. Results are representative of three 
individual experiments. 
A and B. Numbers of iNOS+ (A) or TNFα+ (B) DC (grey bars) and those of iNOS+ (A) or TNFα+ (B) 
non-DC (white bars) in single cell suspensions from the bladder were determined by flow 
cytometry. Bars were stacked to yield the total number of iNOS+ (A) or TNFα+ cells (B). 
C and D.Numbers of NΦG (C) and of DC (D) in single cell suspensions from the bladder were 
determined by flow cytometry. 
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Next, as NO is an important effector molecule against UPEC (48) (77) (64), the cellular 
source of iNOS in infected bladders was determined (Fig. 11). To differentiate between MΦ 
and NΦG, the expression levels of F4/80 and Gr1 on CD11c¯ iNOS+ cells were analyzed. 
NΦG express very high levels of Gr1, but were devoid of F4/80 expression. In contrast, F4/80 
expression and less levels of Gr1 than NΦG on CD11c negative cells characterized MΦ.  
As expected all iNOS producing cells were F4/80 positive, but expressed only low levels 
of Gr1 demonstrating that infiltrating MΦ, but not NΦG were the major source of this innate 
effector molecule. 
 
Fig. 11 . Mainly MΦ express iNOS and TNFα after infection with UPEC 
C57BL/6 mice were infected with 5x108 E.coli 536. After 16 hours, the bladders of infected mice 
were digested with collagenase and stained for F4/80, Gr1 and iNOS without restimulation. Results 
are representative of three individual experiments.  
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7.4. Heterogeneity of MΦ in different compartments involved in UTI  
The data above indicated that MΦ are recruited and involved in the immune defense 
against UTI (Fig. 2, Fig. 11). To further study these immune cells, the composition of murine 
monocytes in the BM, the blood and in the bladder was investigated. Circulating monocytes 
in the blood expressed the surface molecules CD115 (M-CSF Receptor) and F4/80 
(EGF-Receptor) and it has been shown previously (84) (24), that two blood monocyte subsets 
could be distinguished by expression of different levels of Gr1 (85) (Fig. 12). As NΦG or DC 
generally did not express CD115, analysis of cells expressing this molecule specifically 
targeted monocytes.  
Monocytes in the circulation bearing low expression of Gr1 (Gr1LO) have been associated 
with progenitors that constitutively enter non-inflamed tissue (24). In contrast, high 
expression levels of Gr1 (Gr1HI) has been proposed to identify inflammatory monocytes that 
infiltrate infected and inflamed organs (76). Gr1LO monocytes have been shown to express 
high levels of CX3CR1, but low to absent levels of CCR2. Conversely, inflammatory 
monocytes express low levels of CX3CR1, but high levels of CCR2. It has been proposed that 
these chemokine receptors are responsible for the distinct migratory behavior of these subsets, 
but stringent proof of this hypothesis is lacking. 
 
 
Fig. 12. Monocytes in the circulation of non-infected C57BL/6 mice 
Whole blood was subjected to red cell lysis using RCB buffer, washed twice in DMEM and 
expression levels of CD115, F4/80 and Gr1 were analyzed. Results are representative of at least 
ten individual experiments. 
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7.4.1. MΦ subsets in organs involved in UTI 
To investigate whether these two monocyte subsets were also present in the UTI model, 
the composition of monocytes in organs involved in this infection were analyzed (Fig. 13). To 
this end, expression levels of Gr1 on F4/80+ and CD115+ cells were analyzed in the BM, the 
blood and the bladder and the proportions of monocytes (BM and blood) and MΦ (bladder) 
were determined. In addition, absolute cell numbers of MΦ in the bladder were analyzed. In 
the BM more than 90% of CD115 and F4/80 positive monocytes in non-infected and infected 
mice were of the Gr1HI subset (Fig. 13A and B). In contrast, a higher proportion of Gr1LO 
monocytes were found in the blood of non-infected and infected mice, but significant 
differences in the ratio of Gr1LO and Gr1HI monocytes in the BM and the blood of infected 
and non-infected controls were not observed (Fig. 13B). These results suggested that local 
infection of mice with UPEC did not lead to systemic alterations of monocyte subsets, in 
contrast to chronic systemic inflammatory conditions such as atherosclerosis (F. Tacke, 
personal communication) or listeriosis (76).  
Like in the BM and the blood, MΦ in non-infected and infected bladders were comprised 
of Gr1LO and Gr1HI cells (Fig. 13A and B). In contrast to the blood and the BM, the 
proportion of Gr1HI MΦ in the infected bladder was increased significantly (Fig. 13B, C). 
Furthermore, the absolute numbers of Gr1LO and Gr1HI monocytes in infected bladder were 
increased over the non-infected bladder (Fig. 13C), indicating that both monocyte subsets are 
recruited in UTI. 
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Fig. 13. Increased abundance of Gr1LO and Gr1HI MΦ in infected bladders 
C57BL/6 mice were infected with E.coli 536. After 14 hours, infected and non-infected control mice 
were sacrificed and cells from the BM, the blood and the bladder were isolated. Viable, F4/80 and 
CD115 gated cells were analyzed and Gr1 positive cells were divided into Gr1LO and Gr1HI 
monocytes. For the BM, the blood and the bladder the ratio between all viable cells and the 
monocyte subsets were analyzed (A, B).  
Additionally absolute cell numbers in the bladder of both monocyte subsets was calculated in non-
infected and infected bladders (C).  
Data are representative of experiments repeated three times with three mice per group. One 
asterisk indicates a p value <0.05, ** p<0.01, *** p<0.001. 
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Others have shown different expression levels of CCR2 and CX3CR1 on circulating Gr1LO 
and Gr1HI blood monocytes (21, 24). To investigate whether these findings held true also for 
vesical MΦ in UTI, the expression levels of the chemokine receptors CCR2 and CX3CR1 
were determined under homeostatic and infectious conditions (Fig. 14). Indeed, Gr1LO MΦ in 
the bladders expressed high levels of CX3CR1HI, whereas the Gr1HI MΦ subset expressed 
high levels of CCR2 (Fig. 14). These results indicated higher expression of CX3CR1 on Gr1LO 
MΦ and increased levels of CCR2 on Gr1HI MΦ in UTI, consistent with observations by 
others in different infection models (76). 
 
Fig. 14 . Expression of CX3CR1 and CCR2 on bladder MΦ 
Heterozygous CX3CR1 mice were infected with 5x108 E.coli 536. After 16 hours, the bladders of 
infected and non-infected controls were digested with collagenase and stained for CD115, F4/80, 
Gr1 and CCR2. CX3CR1 and CCR2 expression on CD115 and F4/80 positive cells were analyzed. 
The weak black line represents the isotype control for the CCR2 staining and the background 
fluorescence in C57BL/6 mice. Shown are the mean ± SD of groups of 3 mice. Results are 
representative of three individual experiments.  
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7.4.2. Function of MΦ in UTI 
An unresolved question concerns the functionality of the Gr1LO and Gr1HI MΦ in 
infections. To this end, the effector functions of these immune cell subsets in UTI were 
studied. The expression levels of the antimicrobial effector molecules iNOS and 
ß-defensins 1, the ability to phagocytose inoculated UPEC and TNFα secretion were analyzed 
in MΦ from infected animals and compared to infiltrating NΦG (Fig. 15). About 40% of the 
Gr1LO MΦ and 65% of the Gr1HI MΦ subset in the infected bladder expressed ß-defensin 1 
with similiar expression levels. Strikingly, iNOS expression was confined to Gr1LO MΦ, 
while Gr1HI MΦ and NΦG were completely devoid of this molecule. Phagocytosis of UPEC 
could be demonstrated for MΦ and NΦG, but the percentage of cells that had phagocytosed 
UPEC were significantly higher in NΦG than in MΦ. In contrast, the mean fluorescence 
intensity (MFI) of TNFα−secreting cells was significantly higher in MΦ than in NΦG. 
Furthermore the percentage of TNFα producing Gr1HI MΦ was significantly higher than of 
Gr1LO MΦ. These results demonstrated that each cell subset possessed a characteristic pattern 
of effector functions against UPEC.  
 
Fig. 15. Function of MΦ and NΦG after exposure to UPEC 
C57BL/6 mice were infected with 5x108 E.coli 536 or E.coli 536gfp to analyze phagocytic activity. 
After 16 hours, the bladders of infected mice were digested with collagenase and stained for F4/80, 
Gr1, β-defensin 1, iNOS and TNFα. The mean fluorescence intensity (MFI) represented the gated 
cells in the histogram presented. Results are representative of three individual experiments.  
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To demonstrate the contribution of each cell subset to the absolute amount of these 
antimicrobial functions described above, the portion per cell subset was determined (Fig. 16). 
Gr1LO MФ were the principal cell subset expressing iNOS, whereas Gr1HI MΦ were the major 
source of TNFα in the infected bladder. Inoculated bacteria were predominantly taken up by 
the most abundant NΦG. The murine β-defensin-1 has been shown to be mostly expressed by 
epithelial cells, but in UTI this defensin was widely expressed on several cell subsets 
including phagocytes examined. This calculation suggested again that each immune cell 
subset possessed a characteristic effector function against UTI. 
 
 
Fig. 16. Portion of antimicrobial functionality in the infected bladder 
C57BL/6 mice were infected with 5x108 E.coli 536 or E.coli 536gfp to analyze phagocytic activity. 
After 16 hours, the bladders of infected mice were digested with collagenase and stained for F4/80, 
Gr1, β-defensins 1, iNOS and TNFα. Results are representative of three individual experiments. 
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7.4.3. Table 5. Summary and comparison of different phagocytes involved in UTI 
  NФG Gr1LO MФ Gr1HI MФ 
  
      
        
Gr1  +++  +  ++ 
CD11c   +  
F4/80    +  +  
CD11b  ++  ++  ++ 
CD115   +  + 
CCR2    + 
CX3CR1   ++  + 
        
    
iNOS    +  
β-defensin 1  +  +  + 
UPEC uptake  +++  +  + 
TNFα  +  ++   
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7.5. Tracking of monocytes after in vivo labeling  
To investigate whether the vesical Gr1LO and Gr1HI MΦ populations in UTI were derived 
from circulating Gr1LO and Gr1HI monocytes, a recently described labeling technique using 
fluorescent Lx beads was employed (84). As shown previously, circulating Gr1LO blood 
monocytes could be labeled by injection of fluorescent Lx beads into the tail vein (84), which 
were then phagocytosed predominantly by this subset. However, labeling of Gr1HI monocytes 
required introduction of Lx beads in the absence of circulating Gr1LO monocytes. This was 
achieved by depleting monocytes with clodronate-liposomes (clo-lip) as described previously 
(84). The CCR2+ Gr1HI monocyte subset reconstituted the circulation already after 24 hours, 
whereas CX3CR1+ Gr1LO remained absent for several days (84). In the absence of Gr1LO 
monocytes, injected Lx beads were taken up by Gr1HI monocytes (84), which received the 
beads in the BM from other cells, particularly from marginal zone B cells and NΦG that 
carried the particles to the BM. This labeling system allowed selective labeling of either 
circulating Gr1LO or Gr1HI monocytes.  
To demonstrate efficient depletion of monocytes after administration of clo-lip into the tail 
vein and reconstitution of the blood with Gr1HI monocytes, mice were sacrificed 3 days after 
introducing the clo-lip into the tail vein and the ratio of Gr1LO and Gr1HI monocytes were 
determined (Fig. 17). Three days after depletion, 90% of all circulating monocytes expressed 
high levels of Gr1, as the blood was reconstituted by Gr1HI monocytes from the BM. By 
adoptive transfer experiments these Gr1HI monocytes have been shown to give rise to Gr1LO 
monocytes within 3-6 days (84) (F. Tacke, personal communication). These findings 
demonstrated that the system to label Gr1HI monocytes worked as described by others (84) 
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Fig. 17. Depletion efficacy of monocytes in infected C57BL/6 mice 
Clo-lip were administered into the tail vein of C57BL/6 mice. 80 hours later, whole blood was 
subjected to red cell lysis using RCB buffer and washed twice in DMEM. Expression level of Gr1 on 
CD115+ F4/80+ gated monocytes in monocyte depleted (clo-lip) and non depleted mice (PBS-lip) 
were analyzed by flow cytometry. Shown are the mean ± SD of groups of 3 mice. Results are 
representative of three individual experiments. One asterisk indicates a p value <0.05, ** p<0.01, 
*** p<0.001. 
 
 
 
 
 
 
 
To investigate the migration of Lx positive monocytes into the non-infected and into the 
infected bladder, either Gr1LO or Gr1HI monocytes were labeled by injection of the 
fluorescently labeled Lx beads. Thereafter, mice were infected with UPEC and 24 hours later 
infected and non-infected control mice were sacrificed (Scheme 3).  
clo-lip Lx UPEC
18h 66h 80h
Analysis
Lx UPEC AnalysisGr1
labeling
LO
Gr1
labeling
HI
0h  
Scheme 3. Labeling of circulating Gr1LO and Gr1HI monocytes 
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To show that circulating monocytes had taken up injected Lx beads, blood cells were 
isolated from infected and non-infected controls and the percentage of Lx positive CD115 and 
F4/80 positive cells were analyzed (Fig. 18). Lx labeled Gr1LO or Gr1HI monocytes were 
present in the circulation from infected and non-infected controls. Furthermore, most of the 
cells had taken up one Lx beads, whereas only some had endocytosed multiple Lx beads (Fig. 
18). Approximately 10 to 15% of Gr1LO monocytes were labeled in infected and non-infected 
controls, whereas 35-50% of the Gr1HI subset was efficiently labeled in non-infected and 
infected mice. These data indicated that both monocyte subsets could specifically be labeled 
by this technique. Furthermore, the labeling of Gr1HI blood monocytes was more efficient.  
 
 
Fig. 18. Labeling of Gr1LO and Gr1HI monocytes in the circulation  
Lx beads were administered into C57BL/6 mice to either label Gr1LO or Gr1HI monocytes. Whole 
blood was subjected to red cell lysis using RCB buffer and washed twice in DMEM and the 
percentage of single- or multi-bead positive CD115+ F4/80+ cells were analyzed. Shown are the 
mean ± SD of groups of 3 mice. Results are representative of three individual experiments. 
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7.5.1.  Migration of monocytes into the infected and the non-infected bladder 
The system established as described above was employed to study the migratory fate of 
both monocyte subsets into infected and non-infected bladders (Fig. 19A and B). To account 
for the different labeling efficiency of Gr1LO and Gr1HI monocytes with Lx beads, a 
normalization factor was used (Fig. 19B). This was possible because it has recently been 
shown that unlabelled and labeled circulating monocytes showed similar functionality and 
migratory behavior (F. Tacke, personal communication) (22). Using this system, it was found 
that the migration of Gr1LO and Gr1HI monocytes from the blood into the bladder under 
inflammatory conditions was significantly increased. These experiments suggested that 
bladder MΦ under homeostatic and infectious conditions originated both from Gr1HI and 
Gr1LO blood precursors.  
 
Fig. 19. Migration of monocyte subsets from the circulation into the bladder 
Circulating Gr1LO or Gr1HI monocytes were labeled with fluorescent Lx beads. Two days later mice 
were infected with 5x108 E.coli 536. After 24 hours, the bladders of infected and non-infected 
control mice were digested with collagenase and stained for CD115, F4/80 and Gr1. Lx expression 
on CD115 and F4/80 positive cells were analyzed. Shown are the mean ± SD of groups of 5 mice. 
Results were representative of three individual experiments. Asterisk indicate p values >0.05, 
where results were statistically significant. One asterisk indicates a p value <0.05, ** p<0.01, *** 
p<0.001. 
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7.5.2. Labeling of monocytes in the blood of CCR2-deficient mice 
To determine the role of CCR2 in migration of monocytes into the bladder, 
CCR2-deficient mice were subjected to the labeling system. It has been shown that infiltration 
of MΦ into inflamed organs is decreased in the absence of CCR2 (62) (19), and Gr1HI MΦ 
have been proposed to be CCR2-dependent. To analyze the contribution of CCR2 in the 
labeling efficiency of circulating monocytes, Lx expression on blood CD115+ F4/80+ 
monocytes were analyzed (Fig. 20).  
As already observed in CCR2-competent mice (Fig. 18), labeling of circulating Gr1HI 
monocytes in infected mice was more efficient than labeling of the Gr1LO counterparts. 
However, labeling of Gr1HI monocytes in CCR2-deficient mice under non-inflammatory 
conditions was smaller than that of Gr1LO monocytes (Fig. 20), suggesting that CCR2 affected 
the labeling efficacy of Gr1HI monocytes in the blood. Nevertheless, both MΦ subtypes could 
specifically be labeled, allowing analysis of their migration pattern in UTI.  
   
Fig. 20. Influence of CCR2 expression on labeling efficiency of monocyte subsets  
Lx beads were administered into CCR2-deficient mice to label either Gr1LO or Gr1HI monocytes. 
Whole blood was subjected to red cell lysis using RCB buffer and washed twice in DMEM and the 
expression level of Lx on CD115+ F4/80+ cells were analyzed. Shown are the mean ± SD of groups 
of 3 mice. Results are representative of three individual experiments. 
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7.5.3. Gr1LO and Gr1HI monocytes infiltrate the CCR2-deficient bladder  
Labeling of either Gr1LO or Gr1HI monocytes in the circulation of CCR2-deficient mice 
enabled to monitor the contribution of CCR2 in monocyte trafficking into the bladder. 
Surprisingly, infiltration of CCR2-deficient Gr1LO and Gr1HI monocytes still occurred in UTI, 
indicating CCR2 independent migration into infected bladders (Fig. 21A). Nevertheless, the 
abundance of both MФ subsets in the infected bladder was significantly decreased in the 
absence of CCR2 (Fig. 21C). In contrast, CCR2-mediated differences were not observed 
under homeostasis (Fig. 21B). These findings demonstrated that CCR2 contributed to the 
abundance of both Gr1LO and Gr1HI precursors in UTI, but was not essential for this process.  
 
Fig. 21. Monocyte subsets in the bladder 
Circulating monocytes were labeled with fluorescent Lx beads. Two days later C57BL/6 and 
CCR2-deficient mice were infected with 5x108 E.coli 536. After 24 hours, the bladders of infected 
and non-infected control mice were digested with collagenase and stained for CD115, F4/80 and 
Gr1. Lx expression on CD115 and F4/80 positive cells were analyzed. Shown are the mean ± SD 
of groups of 5 mice. Results are representative of three individual experiments. One asterisk 
indicates a p value <0.05, ** p<0.01, *** p<0.001. 
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7.6. CCR2-dependent migration of monocytes  
These results described above could either be due to a role of CCR2 in recruitment of 
monocytes to the bladder, or to a role of CCR2 in emigration of monocytes from the BM into 
the blood, as very recently suggested (76). To distinguish between these two possibilities, the 
composition and abundance of monocytes were analyzed in mice, where the two monocyte 
subsets were neither depleted nor labeled. To this end, Gr1 expression on CD115+ F4/80+ 
monocytes in the BM, the blood and the bladder were analyzed in infected mice and in non-
infected control animals (Fig. 22).  
In the BM, proportions of monocyte subsets were similar in the presence and absence of 
CCR2 (Fig. 22). In the blood and the bladder, however, CCR2 significantly affected these 
proportions. The percentage of blood Gr1HI monocytes were lower in non-infected 
CCR2-deficient mice. In infection, however, this proportion in the blood was unaltered by 
CCR2. In the bladder, the percentage of Gr1HI MΦ in infected CCR2-competent mice was 
markedly increased, whereas CCR2-deficient mice showed a higher proportion of Gr1LO MΦ. 
These data suggested that CCR2 contributed to the proportion of monocytes in the circulation 
and this may subsequently affected the MΦ proportions in infected CCR2-deficient bladders. 
These differences in the infected CCR2-deficient bladder might be due to increased 
infiltration of Gr1LO MΦ into the deficient bladder or to abolished infiltration of Gr1HI MΦ. 
Another possibility could be differences in the composition of blood monocytes, which 
changed the availability of MΦ precursors. 
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Fig. 22. Gr1 expression on monocytes  
C57BL/6 and CCR2-deficient mice were infected with 5x108 E.coli 536. After 14 hours, the 
bladders of infected mice and non-infected controls were digested with collagenase and stained for 
CD115, F4/80 and Gr1. Gr1 expression on CD115 and F4/80 positive cells were analyzed. Results 
are representative of 3 individual experiments. Numbers represents the percentage of infected 
mice. 
 
To discriminate between these possibilities, the proportions of monocyte susbets were 
determined in these organs and additionally the number of monocytes in bladder were 
analyzed (Fig. 23). Differences in the proportion of Gr1LO and Gr1HI monocytes in the BM of 
C57BL/6 and CCR2-deficient mice were not observed. In contrast, the percentage of both 
monocyte subsets in the circulation and the bladder of infected CCR2-deficient mice were 
reduced significantly, indicating less abundance of circulating monocytes in CCR2-deficient 
mice. These data suggested that in addition to its role in immigration of monocytes into 
infected tissue, CCR2 might contribute to the emigration of monocytes from the BM into the 
circulation. This led to decreased numbers of monocytes in the blood, which subsequently 
diminished the number of MΦ in the infected bladder. 
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Fig. 23. Proportions and absolute cell numbers in different organs involved in UTI 
C57BL/6 and CCR2-deficient mice were infected with 5x108 E.coli 536. After 14 hours, cells from 
the BM, the blood and the bladders of infected mice and non-infected controls were isolated and 
stained for CD115, F4/80 and Gr1. Gr1 expression on CD115 and F4/80 positive cells were 
analyzed. Shown are the mean ± SD of groups of 5 mice. Brackets with numbers indicate p values 
where results were statistically significant. Results are representative of 3 individual experiments. 
One asterisk indicates a p value <0.05, ** p<0.01, *** p<0.001. 
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8. DISCUSSION 
8.1. Recruitment of DC into the bladder after instillation of UPEC 
The early defense against bacterial infections is thought to depend mainly on resident 
tissue cells and innate immune effectors such as NΦG (32) (55). A role of DC as innate 
effectors has recently been demonstrated in several experimental models (15, 60). In 
particular, a DC subpopulation termed Tip-DC was critical for the defense against infection 
with the gram-positive bacterium Listeria monocytogenes. Its absence in CCR2-deficient 
mice resulted in high susceptibility to this infection (77). Based on these findings, the role of 
DC was studied in bacterial UTI, one of the most prevalent infections world-wide. DC 
appeared in the bladder as fast as NΦG and MΦ, implying recruitment from the circulation. 
Expression of F4/80 at intermediate levels and high or low expression levels of CD11b was 
noted, consistent with previous studies examining the phenotype of DC in other non-
lymphoid tissues (41, 62). In addition, a considerable population of DC with phenotypical 
characteristics of Tip-DC was found, including their absence in CCR2-deficient mice, 
intermediate expression of CD11b, expression of iNOS and secretion of TNFα. These 
findings are the first to describe DC recruitment to the bladder in UTI. Furthermore, they 
represent the first description of Tip-DC in an infection model other than listeriosis. 
8.2. CCR2-dependent cells are dispensable for bacterial clearance 
The CCR2 ligand, MCP-1 (CCL-2), has been shown to be secreted in cystitis and 
pyelonephritis (34) (11), suggesting a functional role in these infections. However, bacterial 
clearance from bladders of infected CCR2-deficient mice was unchanged. This independence 
of CCR2+ cells indicated that MCP-1 secretion was not essential for innate defense against 
UTI. Furthermore, it implied that Tip-DC were dispensable for this defense. This discrepancy 
to the situation in listeriosis may be explained by differences in the immune response elicited 
by infections with gram-positive Listeria and gram-negative E.coli. Alternatively, immune 
mediators that could replace the functionality of Tip-DC may reside in the bladder, but not in 
the spleen. In support of the latter possibility, vesical TNFα- and iNOS-producing MΦ were 
abundant in the absence of CCR2, so that the lack of Tip-DC did not significantly deplete the 
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supply of these immune mediators. TNFα and iNOS have been shown to be crucial in 
experimental models of other bacterial infections (48) (77). In UTI, both mediators were 
produced in high amounts (48) (64). However, a functional role in this infection has not been 
proven, although some studies reported partial dependence on iNOS in mice deficient for this 
enzyme or upon chemical inhibition of NO (59) (63). The role of TNFα has not been 
experimentally addressed yet. This cytokine performed pleiotropic functions relevant in 
infections, such as MΦ activation or recruitment of NΦG (48).The number of NΦG were not 
reduced in the bladders of CCR2-deficient mice, implying that the factors crucial in their 
recruitment, such as CXCL8 and TNFα must have been functionally available without 
Tip-DC. Indeed, vesical TNFα−production was detectable in these animals, albeit at lower 
levels. However, the demonstration of unaltered clearance of UPEC in Tip-DC-deficient 
CCR2-deficient bladders indicated dispensability of factors produced by this DC subtype in 
UTI.  
8.3. DC are dispensable for innate clearance, but take up inoculated UPEC  
These findings fundamentally questioned the necessity of DC for the innate defense against 
UTI. Indeed, in mice depleted of DC, UPEC were cleared as efficiently as in non-depleted 
controls. The dispensability of all DC for bacterial clearance did not exclude a supportive role 
of these cells in the innate defense against UTI, for example by secretion of proinflammatory 
cytokines.  
Nevertheless, EM revealed cells with dendritic protrusions in the uroepithelium and 
bladder submucosa, which contained neither the segmented nuclei of NΦG, nor large 
lysosomes typical of MΦ. The surprisingly early appearance of DC two hours after infection 
may allow these cells to capture UPEC at an early stage of infection. Using UPECgfp, this 
uptake was shown by flow-cytometry and microscopically. High levels of MHC class II and 
costimulatory molecules, in particular on those DC that had phagocytosed UPEC implied a 
suggestive role in antigen presentation of UPEC. Importantly, expression of these molecules 
required the presence of CCR2. In the absence of this receptor, MHC class II+ DC and DC 
that had phagocytosed UPEC were markedly reduced. It has been suggested that CCR2 may 
mediate maturation of DC rather than their recruitment (14). In this case, lack of CCR2 would 
result in an increased population of DC that had been unable to express MHC class II. Indeed, 
such an increase was found, but it was not statistically significant.   
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Nevertheless, the efficient recruitment of large numbers of DC bearing an activated and 
mature phenotype into the bladder uroepithelium was remarkable, and suggests a role in the 
induction of adaptive immunity. This notion is further supported by the observed uptake of 
bacterial antigens by DC, which is required for subsequent antigen presentation to T cells. 
T and B cell-dependent immunity has recently been shown to be able to confer protection in 
experimental re-infection with UPEC (86).  
 
8.4. Recruitment of Gr1LO and Gr1HI monocytes in the bladder 
Infiltration of monocytes into infected and non-infected organs is a well known feature of 
the innate immune defense. Recent work has shown that monocytes can be subdivided into 
cells expressing high or low levels of the Gr1 molecule (24). These monocytes have distinct 
migrational behavior due to distinct expression of chemokine receptors. Circulating Gr1LO 
monocytes have been associated with precursors for resident tissue MΦ expressing high levels 
of CX3CR1, whereas CCR2 expressing Gr1HI monocytes are been described to give rise to 
inflammatory MΦ, which infiltrate inflamed tissue. The present study showed that Gr1LO 
monocytes were the predominant MΦ subset in non-infected bladders, whereas Gr1HI MΦ 
were most prevalent in infected bladders. An increased proportion of the Gr1LO MΦ subset in 
infection was not observed. However, when the absolute cell numbers in the non-infected and 
the infected bladder were calculated, a significant increase also of these cells in infection was 
apparent. These finding illustrates the importance of determining absolute cell numbers, 
which more accurately reflect the situation in an immune response. Furthermore, these 
findings question the current view that the Gr1LO MΦ subset is only a resident cell type. 
Instead, these cells have to be considered also as inflammatory monocytes.  
Further analysis of the Gr1LO subset revealed CCR2-independent expression of iNOS 
exclusively expressed on this MΦ subset. In support of this, the expression of iNOS was not 
altered in CCR2-deficient mice, although the numbers of Gr1LO MΦ were diminished in these 
animals. This could be explained by CCR2 independent recruitment of iNOS-expressing 
Gr1LO MΦ, which represented a minor subpopulation of Gr1LO MΦ. Obviously, only the more 
abundant iNOS-deficient Gr1LO MΦ infiltrated infected bladders in a CCR2-dependent 
manner, and this diminished the total number of Gr1LO MΦ in the infected bladder of 
CCR2-deficient mice significantly. An alternative explanation for the diminished number of 
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Gr1LO MΦ in CCR2-deficient mice is the conversion of Gr1HI into Gr1LO monocytes. It has 
been shown by adoptive transfer experiments that circulating Gr1HI monocytes can convert 
into Gr1LO monocytes. This conversion might also take place in the bladder and the lack of 
Gr1HI MΦ in the CCR2-deficient bladder might contribute to the diminished numbers of 
Gr1LO MΦ in the non-infected and infected bladder. Because Gr1LO MΦ infiltrated the 
bladder in UTI, and because they were involved in executing immune effector functions, 
I suggest replacing the term “resident” MΦ by the more accurate phrase “patroling” MΦ.  
8.5. CCR2 is involved in egress of monocytes from the BM into the blood 
Migration of leukocytes from the BM into the circulation is a well regulated process. 
Under non-inflammatory conditions, the chemokine CXCR4 has been shown to mediate 
homeostatic emigration of monocytes from the BM (9, 56) (61). Furthermore, less retention of 
leukocytes in the BM by diminished interaction of SDF-1 and CXCR4 and therefore 
diminished interactions with members of the integrin family regulate the homeostasis in 
infected organisms. In infections, the numbers of circulating NΦG rise dramatically and this 
has been shown to be mediated by CXCL8, formerly known as IL-8 and MIP-2. Also 
monocyte numbers rise due to regulated egress of precursors from the BM, and this has been 
very recently proposed to be mediated by MCP-1 (CCL-2) (76). Migration of circulating 
monocytes into infected organs is though to be driven by chemotactic signals and their 
receptors on several target cells. CCR1, CCR2 and CCR5 have been shown to contribute to 
this process. Since MCP-1 is produced in the urogenital tract in response to bacterial 
infection, the role of the MCP-1 receptor, CCR2, in migration of monocytes was investigated. 
To this end, a recently described technique to selectively label Gr1LO and Gr1HI monocytes in 
the blood was employed (84). Different labelling efficiency of the Gr1LO and the Gr1HI subset 
had to be taken into account. These differences may be explained by lower uptake of the Lx 
beads by the Gr1LO monocyte subset or by a decreased ratio of cells to Lx beads after 
depletion of the Gr1LO monocyte subset. In conclusion, the labelling technique revealed 
CCR2-independent migration of both Gr1LO and Gr1HI monocytes into infected tissue, 
suggesting that additional mechanisms also contributed to their recruitment, for example 
CCR1 and CCR5, which have been described to mediate monocyte infiltration into inflamed 
organs (33, 46).  
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Under homeostasis, CCR2-deficient mice showed decreased proportion of Gr1HI 
monocytes in the blood and the bladder. In contrast, under infectious conditions the 
proportion was decreased in the bladder of CCR2-deficient mice, but unchanged in the blood. 
These differences in the blood under homeostasis and infectious conditions were due to 
recruitment of blood monocytes from the circulation into the bladder after infection. This 
view has been extended by very recent investigations by others showing that CCR2 mediates 
egress of monocytes out of the BM, rather than from blood to site infection (76). The 
contribution of CCR2 in egress of monocytes out of the BM has not been proven directly in 
this present study, but the altered number and proportion of blood monocytes in 
CCR2-deficient mice suggested that CCR2 contributed to the egress of monocytes out of the 
BM. Thus, the present findings in non-infected and infected CCR2-deficient mice are more 
compatible with this very recent view by others (76). 
Taken together, these findings suggested that decreased or altered monocyte proportions 
and abundance in the infected CCR2-deficient bladder is rather due to decreased abundance of 
blood monocytes in the circulation of CCR2-deficient mice than from diminished recruitment 
of monocytes from the bloodstream into the bladder. 
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8.6. New model of phagocyte infiltration and migration 
The results of the present study warrant extending the current view of cellular infiltration 
in UTI (scheme 1) by a new model shown in Scheme 4. The abundance of vesical phagocytes 
could be shown to be comprised of five, rather than the traditional two subsets (MΦ and 
NΦG): Infiltrating MΦ were comprised of “patroling” Gr1LO and “inflammatory” Gr1HI MΦ. 
Furthermore, two subsets of DC were identified, which could be subdivided in Tip-DC and 
cDC.  
 
Scheme 4. Interplay between infiltrating cells and UPEC infection 
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Typical functions of CCR2-dependent Tip-DC were the secretion of innate immune 
effectors like iNOS and TNFα, whereas cDC were capable of phagocytosis and expressed 
high levels of MHC class II and costimulatory molecules in a CCR2-dependent manner on 
their surface (Scheme 5). Gr1LO MΦ were comprised of CCR2-dependent iNOS-negative and 
CCR2-independent iNOS-producing cells. A typical function of CCR2-dependent Gr1HI MΦ 
was the expression of TNFα, whereas CCR2-independent NΦG was the most phagocytic cell 
type. Interestingly, all hematopoietic cells examined produced β1-defensins, a function 
previously ascribed only to epithelial cells (35).  
 
Cellular pool in
the infected bladder
CCR2 dependence CCR2 independence 
Tip-DC
Gr1  MOHI
Conventional immature DCConventional mature DC
Gr1  iNOS¯ MOLO Gr1  iNOS  MOLO +
Neutrophil Granulocytes
 
Scheme 5. CCR2-dependent and independent cell subsets in the infected bladder  
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The role of CCR2 in phagocyte migration described in the introduction (scheme 2) may be 
extended by the following novel scheme (Scheme 6): These present findings support 
mediating egress from the BM as the major function of CCR2. Furthermore, they demonstrate 
a minor role of CCR2 also in immigration of both Gr1LO and Gr1HI monocytes into infected 
organs and a role of other CCR in this migration process.  
 Bone 
marrow
Blood
Tissue
   Gr1
CCR2
CX3CR1
LO
  LO
HI
Homeostasis?
InflammationCCR2
CCR2
    Gr1
CCR2
HI
HI  
CX3CR1LO
CCRX?
 
Scheme 6. The role of CCR2 in leukocyte migration  
8.7. Future questions to be addressed 
This present study warrants future experiments about MΦ and DC under homeostasis and 
infectious conditions. Questions to be addressed in the future could concern the origin of 
vesical MΦ and DC in UTI, because it is unknown whether these cells were derived from the 
same blood precursor, as recently proposed (21). Furthermore, the possibilities of 
interconversion of DC and MΦ and of Gr1HI MΦ to Gr1LO MΦ need to be addressed. The 
different functional relevance of the two MΦ subsets in the defense against UTI has to be 
established. Likewise, the exact role of CCR2 and its ligand in release of monocytes from the 
BM needs further investigation. The finding that MΦ could be recruited by mechanisms other 
than CCR2 warrants identification of these mediators. Possible candidates include CCR1 and 
CCR5.  
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